Menlo Park, CA, United States of America

Lino Gonzalez, Jr

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 38(Granted Patents)


Company Filing History:


Years Active: 2016-2022

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Lino Gonzalez, Jr.: Pioneering Innovations in Immune Disease Treatment

Introduction

Lino Gonzalez, Jr., a talented inventor based in Menlo Park, California, has made significant contributions to the field of medicine through his innovative ideas and patented technologies. With a total of two patents to his name, he is focused on advancing treatment modalities for immune-related diseases, showcasing his commitment to improving patient outcomes through scientific research and development.

Latest Patents

Gonzalez’s latest patents are titled "Compositions and methods for the treatment of immune related diseases." These inventions relate to novel compositions and the methodologies for utilizing these compositions in the diagnosis and treatment of various immune-related conditions. The dual nature of these patents emphasizes the importance of both diagnosis and therapeutic strategies in tackling complex health issues associated with the immune system.

Career Highlights

Lino Gonzalez, Jr. is currently affiliated with Genentech, Inc., a leading biotechnology company renowned for its groundbreaking work in medicine. His role at Genentech allows him to collaborate with experts and conduct pivotal research that drives forward-thinking solutions in treatments for immune diseases.

Collaborations

Throughout his career, Gonzalez has worked alongside accomplished professionals such as Hilary Clark and Dan L. Eaton. These collaborations have fostered an innovative environment that encourages the sharing of ideas, ultimately enhancing the quality and effectiveness of their research endeavors.

Conclusion

Lino Gonzalez, Jr. exemplifies the spirit of innovation in the realm of medical research. Through his dedicated work at Genentech, Inc. and his significant patents, he continues to pave the way for advancements in the treatment of immune-related diseases, significantly impacting the healthcare landscape with his contributions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…